Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study

OBJECTIVE: To evaluate the efficacy and safety of etanercept (ETN) after 48 weeks in patients with early active non-radiographic axial spondyloarthritis (nr-axSpA). METHODS: Patients meeting Assessment of SpondyloArthritis international Society (ASAS) classification criteria for axSpA, but not modif...

Descripción completa

Detalles Bibliográficos
Autores principales: Maksymowych, Walter P, Dougados, Maxime, van der Heijde, Désirée, Sieper, Joachim, Braun, Jürgen, Citera, Gustavo, Van den Bosch, Filip, Logeart, Isabelle, Wajdula, Joseph, Jones, Heather, Marshall, Lisa, Bonin, Randi, Pedersen, Ron, Vlahos, Bonnie, Kotak, Sameer, Bukowski, Jack F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941178/
https://www.ncbi.nlm.nih.gov/pubmed/26269397
http://dx.doi.org/10.1136/annrheumdis-2015-207596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941178/
https://www.ncbi.nlm.nih.gov/pubmed/26269397
http://dx.doi.org/10.1136/annrheumdis-2015-207596

Ejemplares similares